Live Quote · NASDAQEQRXHealthcare· Biotechnology

EQRx, Inc.

$2.34 2.09%($-0.05)
TickerSpark Score
73/100
Solid
87
Valuation
35
Profitability
60
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EQRX research report →

52-Week Range24% of range
Low
$1.58
Current
$2.34
High
$4.75
Company Overviewwww.eqrx.com

About the company

EQRx, Inc. is a U. S.

CEO
Melanie I. Nallicheri
IPO
2021
Employees
362
HQ
Cambridge, MA, US

Price Chart

-57.06% · this period
$5.45$3.53$1.61Nov 09May 12Nov 09
Valuation
Market Cap
$1.14B
P/E
5.44
P/S
0.00
P/B
0.80
EV/EBITDA
-4.55
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
14.15%
ROIC
30.77%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$205.49M · 326.57%
EPS
$0.43 · 326.32%
Op Income
$-355,877,000
FCF YoY
-57.06%
Performance & Tape
52W High
$4.75
52W Low
$1.58
50D MA
$2.25
200D MA
$2.05
Beta
0.63
Avg Volume
2.95M

Get TickerSpark's AI analysis on EQRX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Nov 9, 23Casdin Eliother755,766
Nov 9, 23Casdin Eliother5,488,164
Nov 9, 23Casdin Eliother8,110,001
Nov 9, 23Casdin Eliother101,010
Nov 9, 23Nallicheri Melanieother626,999
Nov 9, 23Nallicheri Melaniesell1,900,000
Nov 9, 23Nallicheri Melaniesell530,335
Nov 9, 23Nallicheri Melanieother626,999
Nov 9, 23Nallicheri Melaniesell3,851,147
Nov 9, 23Nallicheri Melaniesell1,253,999
Coverage · EQRX

Our EQRX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EQRX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EQRX report →
Internal Compare

Similar companies

Peers in the same neighborhood.